Prograf 0.5 MG capsule 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FCZ4H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,324
Award facts
- Contract value 100% obligated
- $17,324.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,324.38 to AmerisourceBergen Drug Corp for the supply of Prograf 0.5 mg capsules (100-count units) on January 13, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price contract, which was competitively awarded with no set-aside designation, is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $1 billion contract vehicle that extends through December 2031 and serves as the primary procurement mechanism for pharmaceutical products and medical supplies supporting military healthcare programs globally.
Prograf (tacrolimus) is an immunosuppressant medication commonly used in transplant medicine and certain autoimmune conditions, making this delivery order consistent with the Defense Health Agency's pharmaceutical support requirements for military treatment facilities and veteran healthcare programs. AmerisourceBergen Drug Corp, as a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs. The competitive award demonstrates the contractor's capability to meet federal procurement standards and fulfill essential medical commodity requirements through the DLA's comprehensive pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FCZ4H?
SPE2DR26FCZ4H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FCZ4H worth?
The government has obligated $17,324 on SPE2DR26FCZ4H.
Is contract SPE2DR26FCZ4H an order under another contract?
Yes. SPE2DR26FCZ4H is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCZ4H competed?
The extent of competition for SPE2DR26FCZ4H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award